Deutsche Bank cuts Italy's DiaSorin to 'hold' on 'notable' growth slowdown

DiaSorin SpA

07/11/2025 08:37

** Deutsche Bank cuts Italy's DiaSorin DIAS.MI to "hold" from "buy" on its "notable" Q3 growth slowdown

** The 2025 guidance cut by the medical diagnostics group was "broadly expected" due to a delayed flu season, DB says

** DiaSorin missed the opportunity to realign expectations for 2026 and 2027, it notes

** "The stock will struggle until expectations are fully rebased", it adds

** The broker cuts the TP by 35% to 71 euros ($82.80) from 109 euros

** Shares at lowest since March 2017, up to the previous session's close, shares were down 39.4%​ YTD

** Out of 14 analysts that cover DiaSorin, eight rate the stock "strong buy" or "buy",​ four rate "hold" and two rate "strong sell" or "sell" - LSEG data

($1 = 0.8575 euros)

 (Reporting by Philippe Leroy Beaulieu in Gdansk)

 ((Philippe.leroybeaulieu@tr.com))